ICPE 2022
September 17–20, 2022 | New Orleans, LA
Sponsor
August 2022
Carelon Research (formerly HealthCore) is a proud sponsor of ICPE 2022. Visit us in-person at Booth #401/500, connect with our experts, and see our latest research in COVID-19 and pregnancy, among other topics. For more information, please visit eventscribe.net .
SKILLS COURSE
Wednesday, August 24 | 2:00–6:00 pm CEST
Using pharmacoepidemiology database resources to address drug safety research
Presentation on data validation approaches in pharmacoepidemiology
Daniel Beachler, PhD, MHS, Director of Research, Safety & Epidemiology, Carelon Research
Carelon Research presentations
Carelon Research authors are indicated in bold.
|
Presentation |
Session |
Title |
Authors |
Affiliations |
|---|---|---|---|---|
|
Oral Presentations Friday, August 26 |
Pharmacoepidemiologic methods and SARS-CoV-2 |
Chillarige Y1, Hu M1, Feng Y1, Shi X1, Zhou CK2, Wong HL2, Jiao Y1, Lloyd P2, Amend KL3, Beachler DC4, Secora A5, Kline AM6, Clarke TC2, Ogilvie R7, Reich C8, McMahill-Walraven CN9, Seeger JD7, Anderson SA2, Shoaibi A2 |
1Acumen LLC, Burlingame, CA, USA, 2Food and Drug Administration, Silver Spring, MD, USA, 3Optum, Bloomfield Hills, MI, USA, 4Carelon Research, Wilmington, DE, USA, 5IQVIA Government Solutions Inc., Charlottesville, VA, USA, 6CVS Health, Woonsocket, RI, USA, 7Optum Epidemiology, Boston, MA, USA, 8IQVIA, Cambridge, MA, USA, 9CVS Health Clinical Trial Services, Blue Bell, PA, USA |
|
|
Oral Presentations Sunday, August 28 |
Methods: validation |
Jamal-Allial A1, Sponholtz T1, Vojjala SK1, Papazian A1, Eshete B1, Mahmoudpour SH2, Verpillat P2, Beachler DC1 |
1Carelon Research, Wilmington, DE, USA, 2Merck Healthcare KGaA, Darmstadt, Hessen, Germany |
|
|
Posters Friday, August 26 |
Methods in pharmacoepidemiology |
Parlett L1, Neikirk A1, Huang C2, Davidow A3, Haynes K4, Gerhard T2, Rose C5, Strom B2, Horton D2 |
1Carelon Research, Wilmington, DE, USA, 2Rutgers Center for Pharmacoepidemiology and Treatment Science, New Brunswick, NJ, USA, 3New York University, New York, NY, USA, 4Johnson & Johnson, New Brunswick, NJ, USA, 5Thomas Jefferson University, Woodbury, NJ, USA |
|
|
Posters Friday, August 26 |
Methods in pharmacoepidemiology |
Gini R1, Pajouheshnia R2, Hall GC3, Platt RW4, Setoguchi S5, Bazelier MT2, Kaplan S6, Zhou X7, Lanes S8, Man K9, Li L10, Burcu M11, Roberto G12, Dodd C13, Duran CE2, Wientzek-Fleischmann A14, Soman K2, Lai CC15, Marinier K16, Bennett D17, Gardarsdottir H2 |
1Agenzia Reg Della Sanit, Firenze, Italy, 2University of Utrecht, The Hague, Zuid-Holland, Netherlands, 3Gillian Hall Epidemiology Ltd., London, Herts, UK, 4McGill University, Montreal, QC, Canada, 5Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ, USA, 6Pharmaceutical Industries Ltd., Netanya, Israel, 7Pfizer Inc., New York, NY, USA, 8Carelon Research, Wilmington, DE, USA, 9UCL School of Pharmacy, London, UK, 10Sanofi, Bridgewater, NJ, USA, 11Merck & Co., Inc., West Point, PA, USA, 12ARS Toscana, Firenze, Italy, 13Panalgo, Boston, MA, USA, 14Daiichi-Sankyo Europe, Germany, 15National Cheng Kung University, Tainan City, Tainan, Taiwan (Republic of China), 16IQVIA, Courbevoie, France, 17Takeda Pharmaceuticals, Lexington, MA, USA |
|
|
Posters Friday, August 26 |
Pregnancy and lactation |
Jamal-Allial A1, Guzman M1, Crowe CL1, Gallagher K1, Doherty BT1, Hoffman SR1, Avula R1, Kalloo G1, Eshete B1 |
1Carelon Research, Wilmington, DE, USA |
|
|
Posters Friday, August 26 |
Pregnancy and lactation |
Hoffman SR1, Crowe CL1, Guzman M1, Doherty BT1, Gallagher K1, Jamal-Allial A1, Kalloo G1 |
1Carelon Research, Wilmington, DE, USA |
|
|
Posters Friday, August 26 |
Pregnancy and lactation |
Doherty BT1, Lynch S1, Naavaal A2, Li C2, Cole K2, MacPhee L2, Banning L2, Sharma A2, Grabner M1, Stanek E2, Inglis T2 |
1Carelon Research, Wilmington, DE, USA, 2Elevance Health (formerly Anthem, Inc.) Indianapolis, IN, USA |
|
|
Posters Friday, August 26 |
Pregnancy and lactation |
Kalloo G1, Guzman M1, Crowe CL1, Doherty BT1, Gallagher K1, Jamal-Allial A1, Hoffman SR1 |
1Carelon Research, Wilmington, DE, USA |
|
|
Posters Saturday, August 27 |
Drug utilization research |
Hoffman SR1, Lanes S1, Crowe CL1, Daniels K1, Mawanda F2, Schroeder KM2 |
1Carelon Research, Wilmington, DE, USA, 2Eli Lilly and Company, Indianapolis, IN, USA |
|
|
Posters Saturday, August 27 |
Late breakers |
Jamal-Allial A1, Guzman M1, Daniels K1, Avula R1, Gallagher K1 |
1Carelon Research, Wilmington, DE, USA |
|
|
Posters Saturday, August 27 |
Methods in pharmacoepidemiology |
Sponholtz T1, Jamal-Allial A1, Vojjala SK1, Papazian A1, Eshete B1, Mahmoudpour SH2, Verpillat P2, Beachler DC1 |
1Carelon Research, Wilmington, DE, USA, 2Merck KGaA, Darmstadt, Hessen, Germany |
|
|
Posters Sunday, August 28 |
Methods in pharmacoepidemiology |
Hoffman SR1, Gangan N1, Chen X2, Smith JL1, Tave A1, Yang Y1, dosReis S3, Grabner M1 |
1Carelon Research, Wilmington DE, USA 2Elevance Health (formerly Anthem, Inc.), Indianapolis, IN, USA, 3University of Maryland School of Pharmacy, Baltimore, MD, USA |
|
|
Posters Sunday, August 28 |
Methods in pharmacoepidemiology |
Mai X1*, Teng CC1, Gao Y1, Governor S1, He X1, Hoffman SR1, Kalloo G1, Beachler DC1 |
1Carelon Research, Wilmington, DE, USA *Asterisk indicates Carelon Research associate at the time of submission |
|
|
Posters Sunday, August 28 |
Pediatric pharmacoepidemiology |
Parlett L1, Yang Y1, Huang C2, Neikirk A1, Davidow A3, Haynes K4, Gerhard T2, Rose CD5, Strom BL6, Horton DB2 |
1Carelon Research, Wilmington, DE, USA, 2Rutgers Center for Pharmacoepidemiology and Treatment Science, New Brunswick, NJ, USA, 3New York University School of Global Public Health, New York, NY, USA, 4Johnson & Johnson, Malvern, PA, USA, 5Thomas Jefferson University, Woodbury, NJ, USA, 6Biomedical and Health Sciences, Rutgers University, Newark, NJ, USA |
|
|
Posters Sunday, August 28 |
Vaccines |
Hobbi S1, Moll K1, Lufkin B2, Zhou CK3, Shi X2, Fingar KR1, Hu M2, Sheng M4, Joyce JC2, Burrell T4, Chillarige Y2, Beers J1, Saunders-Hastings P5, Muthuri SG1, Edwards KM6, Black S7, Kelman JA8, Reich C9, Amend KL10, Beachler DC11, Ogilvie R10, Secora A9, Seeger JD10, Lloyd P3, Thompson D3, Dimova R3, Obidi J3, Anderson SA3, Forshee RA3, Wong HL3, Shoaibi A3, Shangguan S2 |
1IBM Consulting, Arlington, VA, USA, 2Acumen LLC, Washington, DC, USA, 3Food and Drug Administration, Silver Spring, MD, USA, 4IBM Watson Health, Sacramento, CA, USA, 5Accenture, Ottawa, ON, Canada, 6Vanderbilt University Medical Center, Nashville, TN, USA, 7Coalition for Epidemic Preparedness Innovations (CEPI), Washington, DC, USA, 8Centers for Medicare & Medicaid Services, Baltimore, MD, USA, 9IQVIA, Cambridge, MA, USA, 10Optum, Bloomfield Hills, MI, USA, 11Carelon Research, Wilmington, DE, USA |
|
|
Posters Sunday, August 28 |
Vaccines |
Fuller CC1, Kawai A2, Haynes K3, Coughlin K1, Reynolds JS1, Hawrusik R1, Horgan C1, Calingaert B2, Johannes CB2, Layton JB2, Peterson A3, Praet N4, Willame C4, Yost E5, Brannan C6, McMahill-Walraven CN7, Guzman M8, Jamal-Allial A8, Nair V9, Seals RM10, Wang FT10, Selvan M9, Ma Q9, Platt R1, Gilsenan AW2, Brown J11 |
1Harvard Pilgrim Health Care Institute, Boston, MA, USA, 2RTI Health Solutions, Waltham, MA, USA, 3Johnson & Johnson, Malvern, PA, USA, 4Janssen, Beerse, Antwerpen Belgium, 5Janssen, Titusville, NJ, USA, 6Aetna, Hartford, CT, USA, 7CVS Health Clinical Trial Services, Blue Bell, PA, USA, 8Carelon Research, Wilmington, DE, USA, 9Humana Healthcare Research, Louisville, KY, USA, 10Optum Epidemiology, Boston, MA, USA, 11TriNetX, Cambridge, MA, USA |
|
|
Posters Sunday, August 28 |
Vaccines |
de Luise C1, Lanes S2, Coleman J2, Cai B1, Harty B2, Miller JE2, Payne D1, Kendrick K1, Pearson G3, Truong D4, Newburger JW5 |
1Pfizer Inc., New York, NY, USA, 2Carelon Research, Wilmington, DE, USA, 3National Heart, Lung, and Blood Institute (NHLBI)/NIH, Bethesda, MD, USA, 4University of Utah/Primary Children’s Hospital, Salt Lake City, UT, USA, 5Boston Children’s Hospital, Harvard Medical School, Boston, MA, USA |
